Navigation Links
Codexis Board Elects Pedro I. Mizutani, Raizen EVP, as Director
Date:7/28/2011

REDWOOD CITY, Calif., July 28, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced that Pedro I. Mizutani, Executive Vice President, Upstream Business, Raizen Energia Participacoes S.A, has been elected to the Codexis Board of Directors. Mr. Mizutani serves as the Board representative of Raizen, Brazil's largest sugar and ethanol producer. Raizen holds approximately 16% of Codexis' outstanding shares of common stock and is the company's largest stockholder.

"We are delighted to have Pedro Mizutani join our Board," said Alan Shaw, Ph.D., President and Chief Executive Officer. "He brings a wealth of executive experience in industrial, financial and agricultural operations, as well as an in-depth knowledge of the Brazilian fuels and sugar markets. Mr. Mizutani is widely known and respected in the Brazilian business community, and his deep industry knowledge and strategic counsel will bring immediate value to Codexis."

Mr. Mizutani joined Raizen in June 2011 and has responsibility for all upstream business (production of sugar, ethanol, and bioenergy). From 2000-2010, he was Director at Cosan Group with responsibility for all upstream production, and in 2010 was appointed CEO of Cosan Sugar and Ethanol. Cosan is one of the largest groups in Brazil, with businesses in energy, food, logistics, infrastructure and agricultural property management.

He holds a degree in production engineering from the University of Sao Paulo, an MBA from the Getulio Vargas Foundation and a post-graduate degree in finance from the Methodist University of Piracicaba. He has also attended extension courses in business management at Ohio University and the Kellogg School of Management at Northwestern University. Mr. Mizutani is a member of the Board of Directors of Cosan Group, UNICA, the Brazilian sugar trade association, and Centro de Tecnologia Canavieria, a sugarcane research center in Brazil.

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with shell and carbon capture. Other potential markets for the company's biocatalyst-enabled solutions include chemicals and water treatment. For more information, see www.codexis.com.

Contacts:
Media: Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771 Investors: Henk Adriaenssens, ir@codexis.com, 650.421.8331


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Codexis Reports Second Quarter 2011 Results
2. Codexis and Chemtex to Collaborate on Sustainable Detergent Alcohols for the Household Products Market
3. Codexis to Present at the Pacific Crest and Canaccord Genuity Conferences
4. Codexis to Present at 3 Investor Conferences in June
5. Codexis Achieves Development Milestones With Teva
6. Codexis to Present at Barclays Conference
7. Codexis to Announce First Quarter 2011 Financial Results on May 5, 2011
8. Codexis Names Jacques Beaudry-Losique VP Corporate Development & Strategy
9. Codexis Announces Carbon Capture Progress at ARPA-E Summit
10. Codexis Names David Anton CTO & SVP, Process Development & Manufacturing
11. Codexis to Present at the Jefferies and Pacific Crest Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 2016 United Kingdom Ophthalmic Diagnostic Equipment ... new report, "United Kingdom Ophthalmic Diagnostic Equipment Market ... the United Kingdom Ophthalmic Diagnostic Equipment market. The ... volume (in units) and average prices (USD) within ... Ultrasound Imaging Systems, Corneal Topography Systems, Ophthalmoscopes, Perimeters, ...
(Date:12/5/2016)... -- Spain Glaucoma Surgery Devices Market Outlook to 2022 ... Devices Market Outlook to 2022", provides key market data ... provides value, in millions of US dollars, volume (in ... Canaloplasty Micro Catheters and Glaucoma Drainage Devices. The ... for each of these market segements, and global corporate-level ...
(Date:12/5/2016)... -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ), the ... and manufacturing data that support SB-525, its gene therapy program ... of the American Society of Hematology (ASH) being held in ... 2016. "We have developed an improved gene therapy ... highly competitive, and we remain on track to file an ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on ... user experience. , BOC Global Events & Training Group is a professional event ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “Walking With ... of stories that will inspire the reader to be aware of God's direction in ... of published author, Sanford Smith, retired teacher and active church leader. , ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... NuevaCare, a ... Peninsula region, is proud to announce new city-specific pages as part of its ambitious ... the elderly, they often look, first, for local agencies serving their city. The new ...
(Date:12/6/2016)... ... December 06, 2016 , ... Individuals who seek to reduce ... drinking more water or limiting their exposure to the sun, according to a November ... group Beverly Hills Physicians (BHP) notes that, while preventive measures to help keep ourselves ...
(Date:12/6/2016)... ... 06, 2016 , ... Mount Sinai Health System today announced the creation of ... can confer and order 3D models for their cases. Virtual reality, simulation, and ... times. This resource will be the first of its kind catering to the ...
Breaking Medicine News(10 mins):